World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
101
Citations
51286
World Ranking
7830
National Ranking
444

Overview

Jens Wiltfang is affiliated with the University of Göttingen in Germany, contributing extensively to research primarily in medicine and neuroscience. Their work spans various subfields including psychiatry and mental health, neurology, physiology, cognitive neuroscience, and molecular biology.

The scientist's research covers several key topics such as dementia and cognitive impairment research, Alzheimer's disease research and treatments, functional brain connectivity studies, autoimmune neurological disorders and treatments, neuroinflammation and neurodegeneration mechanisms, tryptophan and brain disorders, as well as bipolar disorder and treatment.

Jens Wiltfang has published in a variety of venues, with significant contributions in the following journals and platforms:

  • Alzheimer's & Dementia
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Journal of Alzheimer's Disease
  • Frontiers in Psychiatry
  • Alzheimer's Research & Therapy

Recent papers authored or co-authored by Jens Wiltfang include:

  • "Mediterranean Diet, Alzheimer Disease Biomarkers, and Brain Atrophy in Old Age," 2021, Neurology
  • "Plasma extracellular vesicle tau and TDP-43 as diagnostic biomarkers in FTD and ALS," 2024, Nature Medicine
  • "Minor neuropsychological deficits in patients with subjective cognitive decline," 2020, Neurology
  • "Subjective cognitive decline and stage 2 of Alzheimer disease in patients from memory centers," 2022, Alzheimer's & Dementia
  • "Genetic Associations Between Modifiable Risk Factors and Alzheimer Disease," 2023, JAMA Network Open

Frequent co-authors collaborating with Jens Wiltfang include Anja Schneider, Oliver Peters, Annika Spottke, Josef Priller, and Emrah Düzel, reflecting sustained research partnerships across numerous projects.

Best Publications

  • Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease

    Denise Harold;Richard Abraham;Paul Hollingworth;Rebecca Sims

  • Erratum: Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease (Nature Genetics (2009) 41 (1088-1093))

    D Harold;R Abraham;P Hollingworth;R Sims

  • Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease.

    Paul Hollingworth;Denise Harold;Rebecca Sims;Amy Gerrish

  • Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis.

    Willemijn J. Jansen;Rik Ossenkoppele;Dirk L. Knol;Betty M. Tijms

  • Improved discrimination of AD patients using beta-amyloid((1-42)) and tau levels in CSF

    F Hulstaert;K Blennow;A Ivanoiu;HC Schoonderwaldt

  • Genetic evidence implicates the immune system and cholesterol metabolism in the aetiology of Alzheimer's disease.

    Lesley Jones;Peter A. Holmans;Marian L. Hamshere;Denise Harold

  • The mechanism of γ-Secretase dysfunction in familial Alzheimer disease

    Lucía Chávez-Gutiérrez;Leen Bammens;Iryna Benilova;Annelies Vandersteen;Annelies Vandersteen

  • Social cognition in attention-deficit hyperactivity disorder (ADHD).

    J. Uekermann;M. Kraemer;M. Abdel-Hamid;B.G. Schimmelmann

  • Presenilin clinical mutations can affect gamma-secretase activity by different mechanisms.

    Mostafa Bentahir;Omar Nyabi;Jan Verhamme;Alexandra Tolia

  • Detection of 14‐3‐3 protein in the cerebrospinal fluid supports the diagnosis of Creutzfeldt‐Jakob disease

    Inga Zerr;Monika Bodemer;Olaf Gefeller;Markus Otto

  • Therapeutic approaches to Alzheimer's disease.

    Hans-Wolfgang Klafki;Matthias Staufenbiel;Johannes Kornhuber;Jens Wiltfang

  • Elevated levels of tau-protein in cerebrospinal fluid of patients with Creutzfeldt–Jakob disease

    Markus Otto;Jens Wiltfang;Hayrettin Tumani;Inga Zerr

  • Prevalence and prognosis of Alzheimer's disease at the mild cognitive impairment stage.

    Stephanie J B Vos;Frans Verhey;Lutz Frölich;Johannes Kornhuber

  • Neurochemical diagnosis of Alzheimer’s dementia by CSF Aβ42, Aβ42/Aβ40 ratio and total tau

    Piotr Lewczuk;Hermann Esselmann;Markus Otto;Juan Manuel Maler

  • Value of CSF beta-amyloid1-42 and tau as predictors of Alzheimer's disease in patients with mild cognitive impairment.

    H. Hampel;S. J. Teipel;T. Fuchsberger;N. Andreasen

  • Large-scale, multicenter study of cerebrospinal fluid tau protein phosphorylated at serine 199 for the antemortem diagnosis of Alzheimer's disease

    Nobuo Itoh;Hiroyuki Arai;Katsuya Urakami;Koichi Ishiguro

  • γ-Secretase Heterogeneity in the Aph1 Subunit: Relevance for Alzheimer's Disease

    Lutgarde Serneels;Jérôme Van Biervliet;Katleen Craessaerts;Tim Dejaegere

  • Tau protein and 14-3-3 protein in the differential diagnosis of Creutzfeldt-Jakob disease.

    M. Otto;J. Wiltfang;L. Cepek;M. Neumann

  • Memantine in moderate-to-severe Alzheimer's disease.

    Stefan Bleich;Jens Wiltfang;Johannes Kornhuber

  • Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimertextquotesingles disease

    Denise Harold;Richard Abraham;Paul Hollingworth;Rebecca Sims

Frequent Co-Authors

Johannes Kornhuber
Johannes Kornhuber University of Göttingen
Oliver Peters
Oliver Peters German Center for Neurodegenerative Diseases
Frank Jessen
Frank Jessen University of Cologne
Michael Wagner
Michael Wagner TU Dresden
Josef Priller
Josef Priller Charité - University Medicine Berlin
Christoph Laske
Christoph Laske University of Tübingen
Michael T. Heneka
Michael T. Heneka University Hospital Bonn
Katharina Buerger
Katharina Buerger Ludwig-Maximilians-Universität München
Emrah Düzel
Emrah Düzel German Center for Neurodegenerative Diseases
Hermann Esselmann
Hermann Esselmann University of Duisburg-Essen

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

While studying Medicine in the USA is a rewarding path, some students are interested in related healthcare careers or seek flexible online degree options. Several affordable online programs can fast-track entry into the healthcare field or help you advance within it.

Healthcare administration is a rapidly growing field, requiring both practical knowledge and leadership skills. For those looking to manage healthcare facilities or systems, the cheapest mha programs online and most affordable mha programs offer accessible, accredited training—ideal for aspiring managers balancing jobs and studies.

Nursing professionals aiming for leadership or advanced practice roles can explore the cheapest online bsn to dnp programs, which streamline the process from bachelor’s to doctorate in nursing.

Those interested in pharmacy have online options, too. The 3-year online pharmd track provides a flexible route to a Doctorate in Pharmacy, making this career pathway more accessible than ever.

These online degrees expand opportunities within the healthcare sector, providing quality education at a lower cost and greater convenience.

Best Scientists Citing Jens Wiltfang

Trending Scientists